Elena Tamborini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Journal: Tumori
Published: June 24, 2026

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

Journal: Familial cancer
Published: June 01, 2026

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

Journal: Endocrine
Published: February 21, 2026

Transcriptomic Analysis of Children/Adolescents and Young Adults Versus Adult Synovial Sarcomas Reveals Age-Related Molecular Features.

Transcriptomic Analysis of Children/Adolescents and Young Adults Versus Adult Synovial Sarcomas Reveals Age-Related Molecular Features.

Journal: Pediatric blood & cancer
Published: January 16, 2026

A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers.

A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers.

Journal: ESMO open
Published: August 09, 2025

Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI).

Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI).

Journal: Pigment cell & melanoma research
Published: August 07, 2025

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Journal: Tumori
Published: July 10, 2025

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Journal: JCO precision oncology
Published: June 11, 2025

Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.

Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.

Journal: Oncotarget
Published: June 10, 2025

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Journal: Frontiers in oncology
Published: May 22, 2025

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Journal: BMJ open
Published: May 16, 2025

Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study.

Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study.

Journal: Frontiers in oncology
Published: April 30, 2025
Showing 1-12 of 102

Last Updated: 09/26/2026